- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01282515
Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT
A Study of Topical Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) and a Phase III Comparative Treatment Study of HAL PDT in Female Genital Erosive Lichen Planus (GELP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Oslo, Norway, 0027
- Rikshospitalet, OsloUniversity hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Women with symptomatically genital ELP, clinically verified by at least one doctor attended to the Vulva clinic.
Untreated for ELP for at least 4 weeks. Written Informed Consent signed Age 18 or above
Exclusion Criteria:
Current pelvic inflammatory disease, genital malignancy, or gynecological infection.
Known or suspected porphyria
Known allergy to hexaminolevulinate or similar compounds (e.g. hexaminolevulinate or aminolevulinic acid) Pregnancy and lactation Participation in other clinical study either concurrently or within the last 30 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ELP active
one PDT treatment with 2 ml hexaminolevulinate 6 mg/ml gel
|
one PDT treatment
|
Active Comparator: topical steroids
treatment with clobetasol propionate 0.05% ointment used daily for 6 weeks
|
continuously daily treatment for 6 weeks
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage change of GELP score and/or VAS score 6 weeks after start of treatment.
Time Frame: 6 weeks
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage change of GELP score and/or VAS score 6 months after start of treatment.
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: anne lise helgesen, md, Research Fellow
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ALH ELP 2/10
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Genital Lichen Planus
-
Novartis PharmaceuticalsCompletedLichen Planus: Cutaneous Lichen Planus, Mucosal Lichen Planus and Lichen PlanopilarisGermany, United States, France
-
Oslo University HospitalCelgene Corporation; AmgenActive, not recruitingLichen Planus of Vulva | Female Genital DiseaseNorway
-
Cairo UniversityUnknownPatients With Oral Lichen PlanusEgypt
-
University of North Carolina, Chapel HillEli Lilly and CompanyRecruitingLichen Planus, Oral | Oral Lichen Planus | Lichen Planus, MucosalUnited States
-
Nourhan M.AlyAlexandria UniversityCompleted
-
Alexandria UniversityCompletedEvaluation of Diode Laser and Topical Steroid Therapy in the Treatment of Erosive Oral Lichen PlanusErosive Oral Lichen PlanusEgypt
-
Pia Lopez JornetCompletedOral Lichen Planus | Oral Lichen Planus Related StressSpain
-
Mashhad University of Medical SciencesUnknownTherapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen PlanusErosive Oral Lichen Planus | Atrophic Oral Lichen PlanusIran, Islamic Republic of
-
Panineeya Mahavidyalaya Institute of Dental Sciences...CompletedOral Lichen Planus Related StressIndia
-
Cairo UniversityCompletedErosive Oral Lichen PlanusEgypt
Clinical Trials on hexaminolevulinate
-
Dr. Te VuongKARL STORZ Endoscopy-America, Inc.WithdrawnColorectal Cancer | Photodynamic Diagnosis
-
Edward MessingImagin MedicalCompleted
-
GE HealthcareWithdrawn
-
PhotocureKARL STORZ Endoscopy-America, Inc.CompletedColorectal CancerGermany
-
GE HealthcareCompleted
-
PhotocureTerminated
-
PhotocureNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
PhotocureTerminatedCervical Intraepithelial NeoplasiaFrance, Germany, Norway
-
University of Roma La SapienzaNot yet recruitingNon-muscle-invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma